Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 4Rectal Neoplasms 2Neoplasms by Site 2Neoplasms 2Colonic Neoplasms 2Urogenital Neoplasms 1Skin Neoplasms 1Skin Diseases 1Renal Insufficiency, Chronic 1Renal Artery Obstruction 1Pulmonary Embolism 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Prostatic Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Opioid-Related Disorders 1Neoplasms, Squamous Cell 1Neoplasms, Basal Cell 1Male Urogenital Diseases 1Lung Neoplasms 1Herpes Zoster 1Genital Neoplasms, Male 1Genital Diseases, Male 1Colonic Polyps 1Colon Cancer Screening 1Chronic Pain 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Carcinoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × FED × Prostatic Neoplasms, Castration-Resistant × Clear all
NCT06706921 2024-11-27

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

VA Greater Los Angeles Healthcare System

Phase 4 Recruiting
15 enrolled
Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡